Abstract: A synthetic resin composition comprising 100 parts by weight of a synthetic resin, from 2 to 900 parts by weight of an inorganic filler, and from 0.02 to 20 parts by weight of a copolymer of a compound represented by formula (1) and maleic anhydride, maleic acid, a maleic acid salt or a maleic acid ester; ##STR1## wherein Z is a residue of a compound having from 2 to 8 hydroxyl groups; AO is an oxyalkylene group having from 2 to 18 carbon atoms; R.sup.1 is an unsaturated hydrocarbon group having from 2 to 5 carbon atoms; R.sup.2 is a hydrocarbon or acyl group having from 1 to 40 carbon; a is from 0 to 1,000, b is from 0 to 1,000, c is from 0 to 1,000, l is an integer of from 1 to 8, m is an integer of from 0 to 2, and n is an integer of from 0 to 7, l+m+n=2 to 8, al+bm+cn=1 to 1,000, and n/(l+n).ltoreq.1/3.

Abstract: A controlled release preparation of an active material comprising a reaction product obtained by reacting (a) a copolymer consisting essentially of maleic anhydride and at least one polyalkylene glycol ether represented by formula (I): ##STR1## wherein B represents a residue of a compound having from 2 to 8 hydroxyl groups; R.sup.1 represents an alkenyl group having from 2 to 5 carbon atoms; AO represents an oxyalkylene group having from 2 to 18 carbon atoms or a combination thereof which may be linked together in blocks or at random; R.sup.2 represents a hydrocarbon group having from 1 to 24 carbon atoms; a represents a positive integer, b and c each represents 0 or a positive integer, and a+b+c=2 to 8; l.gtoreq.0, m.gtoreq.0, n.gtoreq.0, and e+m+n=1 to 1000; and (b) an active material. The preparation is soluble both in water and in an organic solvent and exhibits activity for a prolonged period of time.

Abstract: The present invention provides a novel polypeptide which shows higher IFN-.gamma. activity than intact IFN-.gamma. and a method of producing the same.The polypeptides not only possess a remarkable antiviral activity, antitumor activity, immunopotentiating activity but also is highly stable, therefore, it can be used advantageously as pharmaceuticals.

Abstract: An additive for cement comprising, as the effective component, a copolymer of a polyoxyalkylene derivative represented by following formula (1) and maleic anhydride, a hydrolyzed product of the copolymer, or a salt of the hydrolyzed product; ##STR1## wherein Z represents a residue of a compound having a hydroxy group, said compound having from 2 to 8 carbon atoms; AO represents an oxyalkylene group having from 2 to 18 carbon atoms; X represents an unsaturated hydrocarbon group having from 2 to 5 carbon atoms or an unsaturated acyl group having from 2 to 5 carbon atoms; R represents hydrocarbon group having from 1 to 40 carbon atoms; a represents 0 to 1,000; b represents 0 to 1,000; c represents 0 to 1,000; l represents 1 to 7, m represents 0 to 2; and n represents 1 to 7; l+m+n=2 to 8, m/(l+n).ltoreq.1/2, and al+bm+cn.gtoreq.1.

Abstract: A synthetic resin compatibilizer comprising a copolymer of a polyoxyalkylene derivative represented by general formula(I) with maleic anhydride, maleic acid, or a salt or an ester thereof ##STR1## where B represents a residue of a compound having from 2 to 8 hydroxyl groups; AO represents an oxyalkylene group having from 2 to 18 carbon atoms; R.sup.1 represents an unsaturated hydrocarbon group having from 2 to 5 carbon atoms; R.sup.2 represents a hydrocarbon or acyl group having from 1 to 40 carbon atoms; a is from 0 to 1,000; b is from 0 to 1,000; c is from 0 to 1,000; l is from 1 to 8; m is from 0 to 2; and n is from 0 to 7; l+m+n=2 to 8; al+bm+cn=1 to 1,000, and m/(l+n).ltoreq.1/3.The synthetic resin compatibilizer provides a polymer alloy having excellent tensile and flexural strengths.

Abstract: Monomeric human .gamma.-interferon is efficiently produced by subjecting crude human .gamma.-interferon to gel filtration in the presence of a reducing sulfur compound and a protein-denaturing agent.

Abstract: An intact human immune interferon protein and a method for the extraction and purification of intact recombinant human immune interferon is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.

Abstract: An active fragment of human immune interferon and a method for the extraction and purification of this protein fragment is disclosed. This method permits the purification to homogenity of the active fragment of recombinant human immune interferon.